CGG401-AD

Phase 2

Recruiting

Conditions: Alzheimer's diseaseTemporal lobe epilepsyGlioma

Registration Number: JPRN-jRCTs031230338

Lead Sponsor: Kimura Yasuyuki

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 55

Inclusion Criteria

1. Cognitively healthy subjects
1)Persons who the principal investigator or subinvestigator (hereinafter referred to as principal investigator, etc.) judges to be capable of understanding the contents of the explanatory document. 2) Persons who are cognitively healthy. 1) Persons who are cognitively healthy
2)Persons who voluntarily applied for the research and obtained written consent to participate in the research.
3)Men and women who are 50 years of age or older at the time of consent
4)Those whose MMSE score is 24 or higher
5)Subjects who scored 9 or higher on the WMS-R Logical Memory II for subjects with 16 or more years of education, 5 or higher for subjects with 10 to 15 years of education, and 3 or higher for subjects with 0 to 9 years of education.

2. Patients with Alzheimer's disease (including patients with less than moderate or mild cognitive impairment)
1)Persons who are judged by the principal investigator to be capable of understanding the consent document
2)Persons who have given written consent to participate in the research
3)Those who are accompanied by a research assistant who is able to grasp and evaluate the subject's situation, and who have obtained the consent of the research assistant.
4)Men and women who are 50 years of age or older at the time of obtaining consent
5)Patients with Alzheimer's disease of moderate severity or less and patients with mild cognitive impairment who meet the clinical diagnostic criteria of NIA-AA (2011)

3. Patients with temporal lobe epilepsy
1)Persons who are judged by the principal investigator to be capable of understanding the consent document
2)Persons who have given written consent to participate in the research
3)Men and women who are 50 years of age or older at the time of consent
4)Patients with a diagnosis of temporal lobe epilepsy
5)Patients who have been taking antiepileptic drugs for less than three month at the time of consent.

4. Glioma patients
1)Persons who are judged by the principal investigator to be able to understand the consent document
2)Persons who have given written consent to participate in the research
3)Men and women who are 50 years of age or older at the time consent is obtained
4)Those who have been diagnosed with gliomas.

Exclusion Criteria

1. Cognitively normal subjects
1)Patients with developmental and mental health problems that may interfere with the examination
2)Those who have undergone a nuclear medicine examination within 6 months from the time of obtaining consent, from the viewpoint of radiation exposure in nuclear medicine examinations.

2. Patients with gliomas
1)Those who have undergone more than 50% tumor removal, virus-based gene therapy, radiation therapy, bevacizumab, steroids, or anticancer drugs as treatment for gliomas.

3. All subjects
1)Subjects with apparent abnormalities in the medical examination or blood/urine tests at the time of eligibility evaluation, who are judged by the principal investigator, etc. to be at higher than usual risk of adverse health effects due to the PET scan.
2)Subjects who are judged to be unable to suppress their body movements during the examination.
3)Persons with magnetic metals in the body (tattoos, tattoos including art makeup, pacemakers, etc.)
4)Patients with a strong fear of claustrophobia
5)Those with a history of drug allergy
6)Those who are pregnant or may be pregnant, and those who are breast-feeding
7)Subjects with serious complications or those who have a history of serious complications and are judged to be ineligible for this study by the investigators.
8)Those who are regularly taking steroidal and non-steroidal anti-inflammatory drugs or immunosuppressive drugs
9)Participation in a clinical research study involving another intervention, and who have participated in the study for less than one year from the time of the intervention to the time of obtaining consent.
10)Persons who do not consent to the storage of specimens in the Center's biobank.
11)Other subjects who are judged to be ineligible for this study by the principal investigator.